Atlas Trials

Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus

Clinical trial NCT06152042 · TERMINATED

Trial details

NCT number
NCT06152042
Sponsor
Biomea Fusion Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Type 1 Diabetes Mellitus
Start date
2023-12-28
Primary completion
2025-05-20
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.